Deconstructing most recent antiretroviral recommendations.
The selection of antiretroviral therapy for HIV-infected persons initiating treatment is influenced by numerous factors, including efficacy, safety, convenience, drug interactions, and cost, among others. Guidelines have been developed to assist the clinician in choosing regimens that have been found to be effective in clinical studies. Understanding the recommendations of the major US treatment guideline for initial HIV therapy is essential for clinicians caring for such patients.
Wohl
David Alain
DA
AIDS Clinical Trials Unit-Chapel Hill, Division of Infectious Diseases, The University of North Carolina at Chapel Hill, 130 Mason Farm Road, Chapel Hill, NC 27599, USA. wohl@med.unc.edu
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014483:United States Dept. of Health and Human Services
D019380:Anti-HIV Agents